MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
IRIDEX Corporation EPS Ratio 2011-2026 | IRIX
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio IRIDEX Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.59 | -0.47 | -0.46 | - | -0.64 | -1.05 | -1.11 | -1.15 | 1.01 | - | 0.24 | 0.16 | 0.29 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.01 | -1.15 | -0.343 |
Quarterly EPS Ratio IRIDEX Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.09 | -0.06 | -0.1 | - | -0.12 | -0.16 | -0.21 | - | -0.11 | -0.17 | -0.13 | - | -0.11 | -0.14 | -0.15 | - | -0.14 | 0.09 | -0.14 | - | -0.12 | -0.2 | -0.12 | - | -0.13 | -0.18 | -0.22 | - | -0.26 | -0.28 | -0.31 | -0.44 | -0.27 | -0.24 | -0.16 | -1.04 | -0.07 | -0.03 | 0.01 | - | 0.04 | -0.07 | 0.02 | - | 0.05 | 0.03 | 0.05 | - | 0.05 | 0.05 | 0.1 | - | -0.08 | 0.04 | 0.18 | - | 0.04 | 0.1 | 0.02 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.18 | -1.04 | -0.11 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Medical devices industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
-8.58 | $ 2.24 | 0.9 % | $ 3.5 M |  USA |
 |
Acutus Medical
AFIB
|
-2.81 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
-0.48 | - | 3.58 % | $ 2.21 M | USA |
 |
AdaptHealth Corp.
AHCO
|
-0.52 | $ 10.47 | 0.19 % | $ 1.41 B | USA |
 |
Alphatec Holdings
ATEC
|
-0.96 | $ 12.56 | -3.75 % | $ 1.88 B | USA |
 |
Avinger
AVGR
|
-23.3 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
-0.9 | $ 9.61 | -13.93 % | $ 272 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
-0.17 | $ 8.37 | 0.12 % | $ 601 M |  Israel |
 |
Aziyo Biologics
AZYO
|
1.29 | - | 1.37 % | $ 20.5 M | USA |
 |
Butterfly Network
BFLY
|
-0.34 | $ 3.95 | -7.49 % | $ 836 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-0.38 | $ 0.65 | -4.41 % | $ 35.4 M | USA |
 |
Cutera
CUTR
|
-2.87 | - | -10.19 % | $ 1.99 M | USA |
 |
BIOLASE
BIOL
|
-29.4 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-6.99 | - | - | $ 16.4 M | USA |
 |
Boston Scientific Corporation
BSX
|
1.96 | $ 71.28 | 0.11 % | $ 106 B | USA |
 |
Apollo Endosurgery
APEN
|
-0.98 | - | - | $ 475 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-0.51 | $ 3.92 | -3.21 % | $ 146 M |  France |
 |
CONMED Corporation
CNMD
|
1.52 | $ 36.71 | -1.69 % | $ 1.14 B | USA |
 |
Establishment Labs Holdings
ESTA
|
-1.72 | $ 65.5 | 0.75 % | $ 1.94 B |  Costa-rica |
 |
Dynatronics Corporation
DYNT
|
-1.43 | - | 14.99 % | $ 929 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
-1.28 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
-2 | - | -0.57 % | $ 7.12 M | USA |
 |
FONAR Corporation
FONR
|
1.78 | $ 18.44 | -0.05 % | $ 121 M | USA |
 |
InMode Ltd.
INMD
|
1.45 | $ 13.45 | -1.47 % | $ 869 M | Israel |
 |
Abbott Laboratories
ABT
|
3.73 | $ 108.49 | -2.04 % | $ 189 B | USA |
 |
Delcath Systems
DCTH
|
0.08 | $ 9.38 | -3.7 % | $ 336 M | USA |
 |
Bio-Rad Laboratories
BIO
|
-25.6 | $ 267.99 | -0.55 % | $ 7.56 B | USA |
 |
Helius Medical Technologies
HSDT
|
-14.6 | $ 2.07 | -4.61 % | $ 1.26 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
-0.09 | $ 8.9 | -2.2 % | $ 685 M | USA |
 |
AxoGen
AXGN
|
-0.34 | $ 30.94 | -5.53 % | $ 1.42 B | USA |
 |
Align Technology
ALGN
|
5.63 | $ 172.41 | -2.11 % | $ 12.9 B | USA |
 |
Bruker Corporation
BRKR
|
0.76 | $ 34.03 | 0.86 % | $ 5.07 K | USA |
 |
BioSig Technologies
BSGM
|
-0.75 | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
-0.27 | $ 3.67 | -1.87 % | $ 151 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-1.69 | $ 16.66 | -3.2 % | $ 391 M | USA |
 |
Second Sight Medical Products
EYES
|
-0.43 | - | -0.97 % | $ 54.4 M | USA |
 |
Accuray Incorporated
ARAY
|
-0.02 | $ 0.41 | 5.24 % | $ 42.1 M | USA |
 |
IRadimed Corporation
IRMD
|
1.77 | $ 99.67 | -3.04 % | $ 1.27 B | USA |